10-K: SunHydrogen Advances Solar Hydrogen Tech, Reports Net Loss
Annual Report
SunHydrogen, Inc. details significant progress in its solar hydrogen technology development and strategic partnerships, alongside a reduced net loss for fiscal year 2025.
Summary
- Advanced nanoparticle-based and thin-film solar cell-based hydrogen production technologies, achieving key milestones in manufacturability, efficiency, and scale-up.
- Validated nanoparticle-based substrates at 100 cm scales and achieved combined open-circuit photovoltages exceeding 1.8 V, providing a substantial margin for efficient hydrogen production.
- Demonstrated stable performance of nanoparticle semiconductor units for over 100 hours under accelerated conditions, equivalent to approximately 1000 hours under normal use.
- Developed a transformative hydrogen module design that adapts commercial thin-film PV modules into water-splitting hydrogen panels without altering existing manufacturing processes.
- Achieved stable operation and solar-to-hydrogen conversion efficiencies exceeding 10% in small-area (100 cm) thin-film tests, with larger 1200 cm modules demonstrating ~9% efficiency.
- Successfully constructed and demonstrated a 1 m hydrogen panel prototype and unveiled a commercial-size 1.92 m hydrogen reactor module.
- Contracted The Process Group (TPG Engineers) for front-end engineering design of a pilot-scale renewable hydrogen production plant exceeding 25 m of active area.
- Entered a collaboration with the University of Texas at Austin's Center for Electromechanics (UT-CEM) to deploy and operate a >30 m solar-to-hydrogen pilot system for six months.
- Reported a net loss of $8,226,307 for the fiscal year ended June 30, 2025, an improvement from the $9,881,203 net loss in the prior year.
- Operating expenses increased to $5,816,192 in 2025 from $5,001,300 in 2024, primarily due to higher salary and research and development costs.
- Working capital surplus decreased to $37,048,679 as of June 30, 2025, from $42,386,683 in the previous year.
- Cash flow used in operating activities increased to $3,647,278 in 2025 from $1,842,726 in 2024.
- The investment in TECO Fuel Cell Technology was written down to $0 fair value as of June 30, 2025, following TECO's bankruptcy and delisting.
- Identified material weaknesses in internal control over financial reporting, specifically regarding segregation of duties in a small company structure.
Sentiment
Score: 6
Explanation: The sentiment is moderately positive due to significant technological advancements and strategic partnerships that de-risk future commercialization, alongside a reduced net loss. However, the company still faces substantial financial challenges, including a large accumulated deficit, continued operating losses, and the need for future capital raises, coupled with the write-down of a related party investment and identified internal control weaknesses.
Positives
- Achieved significant technological milestones in both nanoparticle-based and thin-film solar cell-based hydrogen production, including validated manufacturability at scale and high solar-to-hydrogen efficiencies.
- Successfully demonstrated a 1 m hydrogen panel prototype and a commercial-size 1.92 m module, confirming viability at commercially relevant sizes.
- Secured key industrial partnerships and collaborations with entities like Honda R&D, CTF Solar, TPG Engineers, and the University of Texas at Austin for pilot deployment and engineering.
- Reduced net loss to $8,226,307 in fiscal year 2025 from $9,881,203 in fiscal year 2024, indicating some financial improvement despite ongoing development.
- Developed a novel panel housing design that enables hydrogen and oxygen separation without expensive ion-exchange membranes, reducing system cost and complexity.
- The company's technology aims for a target cost of $2.50/kg, which could make renewable hydrogen competitive with natural gas hydrogen.
- The US Inflation Reduction Act (IRA) Section 45V Clean Hydrogen Production Tax Credit offers significant incentives (up to $3/kg) for clean hydrogen production, potentially benefiting future commercialization.
Negatives
- Continued to incur a net loss of $8,226,307 for the fiscal year ended June 30, 2025, and has an accumulated deficit of $100,078,550.
- Has never realized revenues to date and expects to continue incurring losses until commercialization.
- Working capital surplus decreased by $5,338,004, and cash used in operating activities increased significantly.
- The investment in related party TECO Fuel Cell Technology was written down to $0 due to bankruptcy and delisting, resulting in a substantial unrealized loss.
- Identified material weaknesses in internal control over financial reporting, specifically concerning segregation of duties, which could pose financial reporting risks.
- Has not adopted an insider trading policy, which could be a corporate governance concern.
- The company's common stock is quoted on the OTCQB, which provides significantly less liquidity than national securities exchanges and is subject to penny stock rules.
Risks
- Limited operating history and no market acceptance for the new technology, with no assurance of commercialization or profitability.
- Requires additional funds in the future through equity or debt financings or collaborative agreements, with no current commitments for such financing.
- May be unable to manage growth or implement its expansion strategy, placing strain on administrative, operational, and financial resources.
- Revenues are dependent upon market acceptance of products, and failure to gain acceptance could lead to curtailment or cessation of operations.
- Faces intense competition from major international and domestic companies with substantially greater resources, potentially leading to loss of market share.
- The demand for the product and the ability to manufacture at commercial scale have not yet been proven.
- Reductions in U.S. federal funding for renewable hydrogen projects may slow industry growth and adversely affect long-term opportunities.
- Proprietary technology may not be adequately protected, and pending patents may not be granted; there is a risk of infringing on the intellectual property rights of others.
- Does not maintain theft or casualty insurance, and only maintains liability and property insurance, potentially leading to uninsured losses.
- Loss of key employees and consultants, including Chief Technology Officer Dr. Syed Mubeen, could adversely affect business development and strategy.
- Loss of strategic alliances, such as research agreements with universities, could impede product development.
- The common stock is subject to extreme volatility and the SEC's penny stock rules, which may decrease liquidity and increase transaction costs.
- Future issuance of common stock upon conversion of Series C Preferred Stock, warrants, and options will result in dilution to existing stockholders.
- The Board of Directors has the authority to create new series of preferred stock without stockholder approval, which could adversely affect common stockholders' rights.
Future Outlook
The company's core mission remains the replacement of fossil fuel-derived hydrogen with truly renewable hydrogen. It aims for its technology to be cost-competitive with brown hydrogen and below the cost of clean hydrogen competitors, with a target cost of $2.50/kg. The company is actively pursuing synergistic strategic investments and acquisitions of complementary hydrogen technologies to grow the hydrogen ecosystem. Management believes it will be able to continue raising funds through the sale of its securities to meet obligations and develop its core business, though there is no assurance of obtaining such capital on favorable terms or at all.
Management Comments
- Our goal is to replace fossil fuels with clean, renewable hydrogen.
- We believe our technology has the potential to be one of – if not the most – economical renewable hydrogen solutions.
- Our process requires no external power other than sunlight and uses efficient and commercial-proven materials.
- We believe renewable hydrogen has already proven itself to be a key solution in helping the world meet climate targets, and we believe our technology potentially offers solutions to the challenges that the hydrogen future presents, including the cost of production and transportation.
- With a target cost of $2.50/kg., we believe our solution has the potential to clear a path for renewable hydrogen to compete with natural gas hydrogen and gain mass market acceptance as a true replacement for fossil fuels.
- SunHydrogen remains fully committed to our patented nanoparticle-based approach to renewable hydrogen production. However, this new methodology, which aligns closely with our nanoparticle technology, benefits from an established manufacturing base.
- Management believes that the Company will be able to continue to raise funds through the sale of its securities to its existing shareholders and prospective new investors which will provide the additional cash needed to meet the Company’s obligations as they become due and will allow the Company to continue to develop its core business.
Industry Context
The renewable hydrogen market is experiencing significant global momentum, projected to reach $1.4 trillion annually by 2050, driven by decarbonization efforts across various sectors. Investment in clean hydrogen is forecasted to increase by 70% in 2025, with production costs expected to fall by 50% by 2030, potentially achieving cost parity with grey hydrogen. Policy frameworks, such as the U.S. Inflation Reduction Act's $3/kg tax credit and the EU's REPowerEU plan, are accelerating market expansion. SunHydrogen's direct solar-to-hydrogen technology, which aims to eliminate external power and costly power electronics, positions it uniquely against conventional electrolyzer companies like Nel ASA and ITM Power. While the competitive field is rapidly advancing with established OEMs scaling up, SunHydrogen's focus on on-site, decentralized production without grid reliance could offer a distinct advantage in specific applications, particularly for distributed and off-grid solutions.
Comparison to Industry Standards
- SunHydrogen's target cost of $2.50/kg for renewable hydrogen aims to be competitive with natural gas hydrogen (grey hydrogen) and below the cost of other clean hydrogen competitors. This is a key benchmark for mass market acceptance.
- The achieved solar-to-hydrogen conversion efficiencies exceeding 10% in small-area (100 cm) tests and ~9% for larger 1200 cm modules are noted as the highest reported for a hydrogen module of this size, indicating strong performance relative to current module-level benchmarks.
- Unlike traditional water electrolysis, which requires external power and costly power electronics, SunHydrogen's direct solar-driven process aims to reduce dependence on grid power and associated infrastructure costs, potentially offering a more streamlined and cost-effective solution compared to competitors like Nel ASA or ITM Power that produce PEM or alkaline electrolyzers.
- The company's development of catalysts and cell designs to operate across acidic or alkaline conditions and tolerate selected non-potable water sources aims to broaden usable water supplies and lower operating costs, addressing a key industry-wide challenge for hydrogen systems that typically require ultra-pure water.
- The collaboration with COTEC to scale up nanoparticle semiconductor units to 100 cm with a manufacturing yield above 90% indicates a focus on commercial-scale production quality, comparable to manufacturing standards in the broader semiconductor and solar industries.
- The pilot deployment of a >30 m solar-to-hydrogen system at UT-CEM's Hydrogen ProtoHub, featuring sixteen 1.92 m photoelectrochemical reactor panels, represents a significant step towards demonstrating commercial viability and scalability in real-world conditions, a critical stage for new entrants in the hydrogen production market.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Technology Officer | Chief Scientific Officer (Dr. Syed Mubeen Jawahar Hussaini) | Dr. Syed Mubeen Jawahar Hussaini | 2025-02 | Promotion from Chief Scientific Officer to Chief Technology Officer. |
| Director | David Raney | 2024-10 | Appointment to the Board of Directors. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Committee Structure | The company currently has no audit committee, compensation committee, or nominations and governance committee due to its small size and Board of Directors. | This structure may limit independent oversight and expertise in critical areas, potentially increasing governance risks, especially given the identified material weaknesses in internal controls. | |
| Audit Committee Financial Expert | The company does not have an audit committee financial expert. | Lack of a financial expert on the audit committee (or equivalent function) could hinder effective oversight of financial reporting and internal controls. | |
| Insider Trading Policy | The company has not adopted an insider trading policy. | Absence of an insider trading policy could expose the company and its insiders to regulatory scrutiny and potential legal issues related to securities trading. |
Legal Proceedings
- The company is not currently a party to, nor is any of its property currently the subject of, any material legal proceedings.
Related Party Transactions
- The company's loan payable to Timothy Young (CEO) was fully repaid, with a balance of $0 as of June 30, 2025, down from $45,829 in the prior year.
- The company's investment in TECO Fuel Cell Technology (formerly TECO 2030), where Timothy Young previously served on the board, was written down to $0 fair value as of June 30, 2025, due to TECO's bankruptcy and delisting.
- The company entered a share allocation agreement with TECO HOLDING AS to receive 13.32% (39,350,000 shares) in Newco, a wholly owned subsidiary of TECO HOLDINGS AS, with a representative of the company to be appointed to Newco's board. The investment in Newco is valued at $0 as of June 30, 2025, due to no readily determinable fair value and impairment.
Stakeholder Impact
- **Shareholders**: Face continued dilution risk from future capital raises and conversions of preferred stock, warrants, and options. The stock's limited liquidity and penny stock status pose challenges. The write-down of the TECO investment represents a loss for shareholders. However, technological advancements and strategic partnerships offer potential long-term value creation.
- **Employees**: The increase in salary expenses and R&D costs suggests continued investment in the workforce and development team. The company considers relations with employees and consultants to be good.
- **Customers/Partners**: The progress in technology development and pilot plant engineering indicates a path towards commercial products, potentially benefiting future customers seeking renewable hydrogen solutions. Existing industrial partners are actively involved in validation and scale-up efforts.
- **Creditors**: The company's working capital surplus, though decreased, and management's belief in its ability to raise future funds, provide some assurance, but the history of losses and need for ongoing financing present risks.
Next Steps
- Continue developing nanoparticle-based tandem semiconductor units and thin-film solar cell-based hydrogen modules towards commercialization.
- Scale up nanoparticle semiconductor unit production to 100 cm with a manufacturing yield above 90% in collaboration with COTEC.
- Deploy and operate a >30 m solar-to-hydrogen pilot system at UT-CEM's Hydrogen ProtoHub for six months to collect comprehensive performance and durability data.
- Utilize the front-end engineering design from TPG Engineers as a blueprint for constructing the first multi-panel hydrogen generation system and for future scale-up to hydrogen farms.
- Pursue synergistic strategic investments in, and acquisitions of, complementary hydrogen technologies to grow the hydrogen ecosystem.
- Address identified material weaknesses in internal control over financial reporting, particularly regarding segregation of duties.
Key Dates
| Date | Description |
|---|---|
| 2009-02-18 | Company incorporated in the State of Nevada. |
| 2009-08 | Timothy Young appointed President, CEO, and Chairman of the Board of Directors. |
| 2010 | Timothy Young appointed Acting CFO. |
| 2011-11-14 | Filed a provisional patent application for Photoelectrosynthetically Active Heterostructures (PAH). |
| 2012-11-14 | Filed a non-provisional patent application claiming priority to the provisional PAH application. |
| 2014-03-21 | Jointly filed a provisional application with the University of California, Santa Barbara for 'Multi-junction artificial photosynthetic cell with enhanced photovoltages'. |
| 2015-03-16 | Filed a non-provisional application for 'Multi-junction artificial photosynthetic cell with enhanced photovoltages'. |
| 2015-03-17 | Filed a corresponding PCT Application for 'Multi-junction artificial photosynthetic cell with enhanced photovoltages'. |
| 2016-09-26 | Jointly filed a provisional application with the University of Iowa for 'Integrated Membrane Solar Fuel Production Assembly'. |
| 2017-03-14 | First patent (US Patent No. 9,593,053B1) covering the structural design of PAH was granted. |
| 2017-09-26 | Filed a PCT Application for 'Integrated Membrane Solar Fuel Production Assembly'. |
| 2018-04-03 | Second patent (US Patent No. 9,593,053B2) covering the method for manufacturing PAH was granted. |
| 2018-04 | Patent for 'Multi-junction artificial photosynthetic cell with enhanced photovoltages' granted in Australia. |
| 2018-10 | Patent (US Patent No. 10,100,415) for 'Multi-junction artificial photosynthetic cell with enhanced photovoltages' granted in the U.S. |
| 2018-12-17 | Board of Directors adopted the 2019 Equity Incentive Plan. |
| 2019-03 | Patent for 'Multi-junction artificial photosynthetic cell with enhanced photovoltages' granted in China and Europe. |
| 2019-03-26 | PCT Application for 'Integrated Membrane Solar Fuel Production Assembly' was nationalized in the U.S. |
| 2021-12-15 | Filed a certificate of designation of Series C Preferred Stock. |
| 2022-01-27 | Company adopted the 2022 Equity Incentive Plan. |
| 2022-01 | Dr. Syed Mubeen Jawahar Hussaini began serving as Chief Scientific Officer. |
| 2022-04 | Dr. Syed Mubeen Jawahar Hussaini became Associate Professor, Department of Chemical and Biochemical Engineering, at the University of Iowa. |
| 2022-10 | Last patent from the international application for 'Multi-junction artificial photosynthetic cell with enhanced photovoltages' granted in India. |
| 2022-11-11 | Entered into a Purchase Agreement with an investor for the sale of up to $45,000,000 of common stock. |
| 2022-11-11 | Entered into a subscription agreement with TECO 2030 ASA and purchased 13,443,875 shares of TECO stock for $7 million. |
| 2022-11-11 | Purchased a bond receivable of TECO for a subscription amount of $3 million. |
| 2023-01 | Timothy Young, CEO, was elected to the board of TECO. |
| 2023-06 | Japan's revised Basic Hydrogen Strategy established utilization targets. |
| 2023-09-08 | Issued 221,052,632 shares of common stock upon conversion of 2,100 Series C preferred shares. |
| 2023-09-12 | Invested in a $5,000,000 certificate of deposit (CD). |
| 2024-01-30 | Dr. Mubeen was awarded stock options. |
| 2024-03-12 | The $5,000,000 certificate of deposit (CD) matured. |
| 2024-04-01 | Renewed lab space rental at $6,400 per month. |
| 2024-04-15 | Decided to abandon the patent application for 'Integrated Membrane Solar Fuel Production Assembly'. |
| 2024-04 | All investors of TECO bonds received an option to convert their bonds to receive one share for every two NOK. |
| 2024-05-24 | Agreed to convert the TECO convertible bond receivable of $3,000,000 and unpaid interest into 15,884,744 shares of TECO stock. |
| 2024-06-19 | Timothy Young ceased to be a director of TECO. |
| 2024-07-01 | Maximum number of shares issuable under the 2022 Equity Incentive Plan increased to 953,548,700 shares. |
| 2024-08-07 | Filed a provisional patent application titled 'CdTe Photovoltaic Module Systems and Methods for Autonomous Water Electrolysis'. |
| 2024-09-10 | Received 15,884,744 shares of TECO stock from bond conversion, bringing total ownership to 29,328,619 shares (13.29% of TECO). |
| 2024-09-15 | Company had 9 full-time employees and several consultants. |
| 2024-10-01 | Extended research agreement with the University of Iowa through September 30, 2025. |
| 2024-10-01 | Extended research agreement with the University of Michigan through September 30, 2025. |
| 2024-10 | David Raney appointed as a director of the Company. |
| 2024-11-19 | Timothy Young was awarded stock options. |
| 2024-11-22 | Issued 231,578,947 shares of common stock upon conversion of 2,200 Series C preferred shares. |
| 2024-11-25 | Filed a provisional patent application titled 'Photoelectrochemical Reactor for Hydrogen Production'. |
| 2024-12-15 | Siemens Mireo Plus H entered passenger service in Germany. |
| 2024-12 | TECO filed for bankruptcy and shares were suspended from trading. |
| 2024-12-17 | Entered a share allocation agreement with TECO HOLDING AS for shares in Newco. |
| 2025-01-03 | Final Treasury/IRS regulations for Section 45V Clean Hydrogen Production Tax Credit issued. |
| 2025-01 | TECO was delisted from Euronext Growth on Oslo Stock Exchange. |
| 2025-02 | Dr. Syed Mubeen Jawahar Hussaini appointed Chief Technology Officer. |
| 2025-06-01 | Entered into a research agreement with the University of Texas at Austin through June 30, 2026. |
| 2025-06-24 | SHARP pilot plant opening ceremony for Sparc Hydrogen JV. |
| 2025-07 | Subsequent legislation set a commence construction deadline of January 1, 2028, for the Section 45V Clean Hydrogen Production Tax Credit. |
| 2025-08-06 | Filed a non-provisional and PCT patent application titled 'CdTe Photovoltaic Module Systems and Methods for Autonomous Water Electrolysis'. |
| 2025-09-10 | Common stock outstanding was 5,438,414,015 shares. |
| 2025-09-12 | Date of filing of the 10-K report. |
Recommendation
holdSunHydrogen has demonstrated significant technological progress and established crucial partnerships, which are positive indicators for its long-term potential in the burgeoning renewable hydrogen market. The reduction in net loss is also a favorable trend. However, the company remains in a pre-revenue, development stage with a substantial accumulated deficit and a clear need for future capital raises, which will likely lead to further shareholder dilution. The write-down of the TECO investment highlights the inherent risks of early-stage investments. Given the high-risk, high-reward nature of the technology and the company's current financial position, a 'hold' recommendation is appropriate. Investors should monitor progress on commercialization, pilot plant results, and future financing activities closely, as these will be critical determinants of future value.
Keywords
Renewable Hydrogen, Solar Hydrogen, Photoelectrochemical, Nanoparticle Technology, Thin-Film Solar Cells, Water Splitting, Clean Energy, Hydrogen Production, SEC Filing, 10-K, SunHydrogen
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.